Bullous Keratopathy Clinical Trial
— AMBUKOfficial title:
Comparative Analysis of Human Amniotic Membrane Graft Versus Contact Lenses in Syntomathic Bullous Keratopathy
Verified date | August 2013 |
Source | Universidad de Valparaiso |
Contact | n/a |
Is FDA regulated | No |
Health authority | Chile: Universidad de Valparaíso |
Study type | Interventional |
The amniotic membrane (AM) is an avascular structure derived from fetus, which is a good
choice for regenerative medicine and effective treatment in eye surface pathologies such as
bullous keratopathy (BK). This disease generates a chronic corneal edema evolving to the
production of vesicles and bullae, chronic eye pain and visual acuity decrease.
Definitive treatment for those patients is corneal transplant; however, donation is not
always available and thus requires long waiting times. The currently available palliative
treatment consists in the use of contact lenses to prevent the corneal epithelium from
falling. However, this may be associated with corneal neovascularization, lens displacement
or loss, infections, and discomfort for the patient.
The objective of this work was to compare the use of amniotic membrane grafts versus contact
lenses in patients suffering from BK awaiting a corneal transplant.
A randomized clinical trial assay was performed with patients with a clinical diagnosis of
BK. Twenty patients were randomized into 2 groups: amniotic membrane and therapeutic contact
lenses. Eye pain intensity (Analog visual scale), visual acuity (Snellen questioner), bullae
and corneal epithelial defects presence, as well as corneal neovascularization and
complications (biomicroscopy) were compared during 6 months.
Status | Completed |
Enrollment | 20 |
Est. completion date | June 2012 |
Est. primary completion date | May 2012 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: All patients with clinical diagnosis of symptomatic bullous keratopathy (corneal bullae, recurrent eye pain, foreign body sensation and photophobia), diagnosed at the Department of Ophthalmology Hospital Carlos Van Buren, Valparaiso, Chile, who were on the waiting list for corneal transplant from January 2008 to October 2011 Exclusion Criteria: Excluded patients were those with medical contraindication to undergo surgery with topical anesthesia, patients with severe systemic conditions and patients with corneal infections. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Chile | Universidad de Valparaíso | Valparaíso |
Lead Sponsor | Collaborator |
---|---|
Universidad de Valparaiso | Investigación y Desarrollo Biotecnológico para Mejorar la Calidad de Vida de las Personas, Universidad de Granada |
Chile,
Adinolfi M, Akle CA, McColl I, Fensom AH, Tansley L, Connolly P, Hsi BL, Faulk WP, Travers P, Bodmer WF. Expression of HLA antigens, beta 2-microglobulin and enzymes by human amniotic epithelial cells. Nature. 1982 Jan 28;295(5847):325-7. — View Citation
Akle CA, Adinolfi M, Welsh KI, Leibowitz S, McColl I. Immunogenicity of human amniotic epithelial cells after transplantation into volunteers. Lancet. 1981 Nov 7;2(8254):1003-5. — View Citation
Canner JK, Javitt JC, McBean AM. National outcomes of cataract extraction. III. Corneal edema and transplant following inpatient surgery. Arch Ophthalmol. 1992 Aug;110(8):1137-42. — View Citation
Cosar CB, Sridhar MS, Cohen EJ, Held EL, Alvim Pde T, Rapuano CJ, Raber IM, Laibson PR. Indications for penetrating keratoplasty and associated procedures, 1996-2000. Cornea. 2002 Mar;21(2):148-51. — View Citation
Courtright P, Lewallen S, Holland SP, Wendt TM. Corneal decompensation after cataract surgery. An outbreak investigation in Asia. Ophthalmology. 1995 Oct;102(10):1461-5. — View Citation
Espana EM, Grueterich M, Sandoval H, Solomon A, Alfonso E, Karp CL, Fantes F, Tseng SC. Amniotic membrane transplantation for bullous keratopathy in eyes with poor visual potential. J Cataract Refract Surg. 2003 Feb;29(2):279-84. — View Citation
Georgiadis NS, Ziakas NG, Boboridis KG, Terzidou C, Mikropoulos DG. Cryopreserved amniotic membrane transplantation for the management of symptomatic bullous keratopathy. Clin Experiment Ophthalmol. 2008 Mar;36(2):130-5. doi: 10.1111/j.1442-9071.2008.01696.x. — View Citation
Jablonski J, Szafran B, Cichowska M. [Treatment of corneal complications after cataract surgery with soft contact lenses]. Klin Oczna. 1998;100(3):151-3. Polish. — View Citation
Kim JC, Tseng SC. The effects on inhibition of corneal neovascularization after human amniotic membrane transplantation in severely damaged rabbit corneas. Korean J Ophthalmol. 1995 Jun;9(1):32-46. — View Citation
Kim JC, Tseng SC. Transplantation of preserved human amniotic membrane for surface reconstruction in severely damaged rabbit corneas. Cornea. 1995 Sep;14(5):473-84. — View Citation
Lee HI, Ha SW, Kim JC. A novel application of amniotic membrane in patients with bullous keratopathy. J Korean Med Sci. 2006 Apr;21(2):324-8. — View Citation
Leibowitz HM, Rosenthal P. Hydrophilic contact lenses in corneal disease. II. Bullous keratopathy. Arch Ophthalmol. 1971 Mar;85(3):283-5. — View Citation
López Ferrando N, Celis Sánchez J, González Del Valle F, López Mondéjar E. [Monolayered amniotic membrane transplantation as a palliative treatment for bullous keratopathy]. Arch Soc Esp Oftalmol. 2004 Jan;79(1):27-31. Spanish. — View Citation
Maeno A, Naor J, Lee HM, Hunter WS, Rootman DS. Three decades of corneal transplantation: indications and patient characteristics. Cornea. 2000 Jan;19(1):7-11. — View Citation
Mejía LF, Santamaría JP, Acosta C. Symptomatic management of postoperative bullous keratopathy with nonpreserved human amniotic membrane. Cornea. 2002 May;21(4):342-5. — View Citation
Nishida T. Cornea: Fundamentals of cornea and external disease. St. Louis, Mosby. 1997; p. 3-27.
Panda A, Pangtey MS, Sony P. Response to symptomatic management of postoperative bullous keratopathy with nonpreserved human amniotic membrane. Cornea. 2003 Mar;22(2):187; author reply 187-8. — View Citation
Pires RT, Tseng SC, Prabhasawat P, Puangsricharern V, Maskin SL, Kim JC, Tan DT. Amniotic membrane transplantation for symptomatic bullous keratopathy. Arch Ophthalmol. 1999 Oct;117(10):1291-7. — View Citation
Sangwan VS, Burman S, Tejwani S, Mahesh SP, Murthy R. Amniotic membrane transplantation: a review of current indications in the management of ophthalmic disorders. Indian J Ophthalmol. 2007 Jul-Aug;55(4):251-60. Review. — View Citation
Shimmura S, Shimazaki J, Ohashi Y, Tsubota K. Antiinflammatory effects of amniotic membrane transplantation in ocular surface disorders. Cornea. 2001 May;20(4):408-13. — View Citation
Smiddy WE, Hamburg TR, Kracher GP, Gottsch JD, Stark WJ. Therapeutic contact lenses. Ophthalmology. 1990 Mar;97(3):291-5. — View Citation
* Note: There are 21 references in all — Click here to view all references
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Age | In years | At the enrolling moment | No |
Other | Sex | Male or Female | At the enrolling moment | No |
Other | Affected eye | left eye or right eye | At the enrolling moment | No |
Primary | Ocular pain | Evaluated by using a visual analogue scale ranging from 0 to 10 | 6 months | No |
Secondary | Visual acuity | Snellen scale | 6 months | No |
Secondary | Corneal Neovascularization | Evaluation using a bio-microscope | 6 months | No |
Secondary | Corneal epithelial defects | Evaluation using a bio-microscope per quadrant with fluorescein test | 6 months | No |
Secondary | Complications | Evaluation using a bio-microscope | 6 months | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03248037 -
Trial of Netarsudil for Prevention of Corticosteroid-induced Intraocular Pressure Elevation
|
Phase 3 | |
Enrolling by invitation |
NCT05956535 -
Air Optix® Night and Day® Aqua Therapeutic Wear
|
||
Recruiting |
NCT02020044 -
Outcome After Descemet Membrane Endothelial Keratoplasty (DMEK) and Ultra-thin Descemet Stripping Automated Endothelial Keratoplasty (DSAEK)
|
N/A | |
Recruiting |
NCT03407755 -
Air Versus SF6 for Descemet's Membrane Endothelial Keratoplasty (DMEK)
|
N/A | |
Completed |
NCT01448213 -
Comparison of Two Steroid Regimens to Prevent Transplant Rejection After Corneal Transplant (DMEK)
|
Phase 2 | |
Completed |
NCT03450954 -
Long Term Results of Amniotic Membrane Transplant in Bullous Keratopathy Patients
|
N/A | |
Completed |
NCT01106274 -
The Effects of Riboflavin/ Ultraviolet-A Corneal Cross-linking on the Signs and Symptoms of Bullous Keratopathy
|
N/A | |
Completed |
NCT03763721 -
The ADVISE Study: Advanced Visualization In Corneal Surgery Evaluation
|
N/A | |
Completed |
NCT05891106 -
AONDA Therapeutic Indication Study I
|
||
Active, not recruiting |
NCT04894110 -
Study of Safety and Tolerability of EO2002 in the Treatment of Corneal Edema
|
Phase 1 | |
Completed |
NCT00659308 -
Amniotic Membrane and Anterior Stromal Puncture to the Treatment of Symptomatic Bullous Keratopathy
|
N/A | |
Completed |
NCT01122043 -
The SNEC DSAEK EndoGlide Clinical Trial
|
N/A | |
Completed |
NCT00800111 -
Study of Endothelial Keratoplasty Outcomes
|
N/A | |
Recruiting |
NCT05636579 -
Study to Assess Safety and Tolerability of Multiple Doses of EO2002
|
Phase 1 | |
Recruiting |
NCT04319848 -
Safety and Efficacy of Tissue Engineered Endothelial Keratoplasty
|
Phase 1 | |
Recruiting |
NCT05436665 -
The Belgian Endothelial Surgical Transplant of the Cornea
|
N/A | |
Not yet recruiting |
NCT02736877 -
Corneal Transplantation Guided by OCT RESCAN
|
N/A |